BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/8/2024 4:58:17 AM | Browse: 263 | Download: 905
 |
Received |
|
2024-01-10 14:18 |
|
Peer-Review Started |
|
2024-01-10 14:18 |
|
First Decision by Editorial Office Director |
|
2024-04-13 05:51 |
|
Return for Revision |
|
2024-04-13 05:51 |
|
Revised |
|
2024-05-31 14:40 |
|
Publication Fee Transferred |
|
2024-06-24 13:22 |
|
Second Decision by Editor |
|
2024-06-21 02:39 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-06-21 06:02 |
|
Articles in Press |
|
2024-06-21 06:02 |
|
Edit the Manuscript by Language Editor |
|
2024-07-02 05:16 |
|
Typeset the Manuscript |
|
2024-07-10 02:24 |
|
Publish the Manuscript Online |
|
2024-08-08 04:58 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Research progress on the development of hepatocyte growth factor/c-Met signaling pathway in gastric cancer: A review
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wu-Jie Wei, Ya-Li Hong, Yi Deng, Guan-Liang Wang, Jiang-Tao Qiu and Fang Pan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fang Pan, N/A, Doctor, Doctor, Department of Oncology, People's Hospital of Chongqing Hechuan, No. 1366 Hill'an Avenue, Nanjin Street Office, Hechuan District, Chongqing 401520, China. panfang124@163.com |
| Key Words |
Targeted therapy; Hepatocyte growth factor and its receptor; Gastric cancer; Prognosis assessment; Review |
| Core Tip |
Hepatocyte growth factor (HGF) and its receptor, c-Met, play important roles in the occurrence, development, and treatment of gastric cancer (GC). This review aimed to explore the function of the HGF/c-Met signaling pathway in GC and its potential targeted therapeutic mechanisms. As one of the most common malignant tumors in the world, GC has a complex pathogenesis and limited therapeutic options. Therefore, a thorough understanding of the molecular mechanism of GC is very important for the development of new therapeutic methods. The HGF/c-Met signaling pathway plays an important role in the proliferation, migration, and invasion of GC cells and has become a new therapeutic target. |
| Publish Date |
2024-08-08 04:58 |
| Citation |
Wei WJ, Hong YL, Deng Y, Wang GL, Qiu JT, Pan F. Research progress on the development of hepatocyte growth factor/c-Met signaling pathway in gastric cancer: A review. World J Gastrointest Oncol 2024; 16(8): 3397-3409 |
| URL |
https://www.wjgnet.com/1948-5204/full/v16/i8/3397.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v16.i8.3397 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
